Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Protein levels in blood may shed light on preterm birth risk

NCT ID NCT07626385

Knowledge-focused Sponsor: Batman Training and Research Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at a protein called osteopontin in the blood of pregnant women whose water broke too early (PPROM). Researchers compared 71 women with early rupture to those with normal-term rupture to see if protein levels differ. The goal was to learn more about the biology behind preterm birth, not to test a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

71 people

The number who actually took part.

Started

Apr 2026

Finished

May 2026

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Case Group (PPROM): Women were eligible for the PPROM group if they met all the following criteria: confirmed diagnosis of PPROM by clinical and/or ancillary tests, gestational age between 24+0 and 36+6 weeks, singleton pregnancy, age 18 years or older, and provision of written informed consent. Control Group (Term ROM): Women were included in the control group if they met all the following criteria: rupture of membranes at term (gestational age ≥37+0 weeks), singleton pregnancy, age 18 years or older, provision of written informed consent, absence of signs of active infection, and no history of additional systemic diseases.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * For the case group (PPROM): * Gestational age between 24+0 and 36+6 weeks * Singleton pregnancy * Age ≥18 years * Provision of written informed consent * Confirmed diagnosis of PPROM by clinical and/or ancillary tests * For the control group (term rupture of membranes): * Gestational age ≥37+0 weeks * Rupture of membranes * No signs of active infection * Singleton pregnancy * Age ≥18 years * Provision of written informed consent * No history of additional systemic diseases Exclusion Criteria (for both groups): * Multiple pregnancy * Major fetal anomaly * Fetal distress * Intrauterine growth restriction (IUGR) * Clinical chorioamnionitis * Systemic infection * Autoimmune or chronic inflammatory disease * Smoking * History of malignancy * Gestational trophoblastic disease * Diabetes mellitus * Preeclampsia * Other serious obstetric complications

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Preterm labor are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Obstetric Labor, Premature preterm premature rupture of the membranes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Preterm labor

Contacts and locations

Locations

  • Private Zilan Hospital

    Batman, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.